605 related items for PubMed ID: 23773640
1. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[Abstract] [Full Text] [Related]
2. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T.
J Pediatr; 2006 Aug; 149(2):237-40. PubMed ID: 16887442
[Abstract] [Full Text] [Related]
3. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
4. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A.
Circulation; 2006 Jun 06; 113(22):2606-12. PubMed ID: 16735679
[Abstract] [Full Text] [Related]
5. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
6. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun 21; 8(3):208-10. PubMed ID: 16787593
[Abstract] [Full Text] [Related]
7. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, Qi JG, Liu XQ, Chen YH, Wang YL, Li XY, Jin HF, Du JB.
World J Pediatr; 2020 Dec 21; 16(6):607-613. PubMed ID: 32232677
[Abstract] [Full Text] [Related]
8. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct 21; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
9. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
Arthritis Rheumatol; 2015 Jul 21; 67(7):1943-50. PubMed ID: 25778686
[Abstract] [Full Text] [Related]
10. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY, Ding Y.
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar 15; 25(3):244-249. PubMed ID: 36946157
[Abstract] [Full Text] [Related]
11. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
Acta Paediatr; 2010 Oct 15; 99(10):1578-83. PubMed ID: 20491705
[Abstract] [Full Text] [Related]
12. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May 15; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
13. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
Hwang JY, Lee KY, Rhim JW, Youn YS, Oh JH, Han JW, Lee JS, Burgner D.
Arch Dis Child; 2011 Nov 15; 96(11):1088-90. PubMed ID: 20551193
[Abstract] [Full Text] [Related]
14. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
PLoS One; 2015 Nov 15; 10(12):e0144603. PubMed ID: 26658843
[Abstract] [Full Text] [Related]
15. Marker of T-cell activation is elevated in refractory Kawasaki disease.
Suzuki H, Suenaga T, Takeuchi T, Shibuta S, Yoshikawa N.
Pediatr Int; 2010 Oct 15; 52(5):785-9. PubMed ID: 20487370
[Abstract] [Full Text] [Related]
16. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Oct 15; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
17. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
Pediatr Infect Dis J; 2008 Feb 15; 27(2):155-60. PubMed ID: 18174868
[Abstract] [Full Text] [Related]
18. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
Sánchez-Manubens J, Antón J, Bou R, Iglesias E, Calzada-Hernandez J, Borlan S, Gimenez-Roca C, Rivera J, Kawasaki Disease in Catalonia Working Group.
Rheumatol Int; 2016 Jul 15; 36(7):905-10. PubMed ID: 27215220
[Abstract] [Full Text] [Related]
19. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I.
Clin Immunol; 2002 May 15; 103(2):161-8. PubMed ID: 12027421
[Abstract] [Full Text] [Related]
20. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
Guo MM, Tseng WN, Ko CH, Pan HM, Hsieh KS, Kuo HC.
Allergy; 2015 Mar 15; 70(3):310-8. PubMed ID: 25585854
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
